Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: The international prospective primary prevention study in hypertension (IPPPSH)

Journal of Hypertension

Volumn 3, Issue 4, 1985, Pages 379-392

  Bühler, Fritz R ^a   Baker, J L ^a,h,l   Bolli, P ^a,i,l   Brugger, M ^a,l   Van Brummelen, P ^a,h   Buhler F R ^b,l   Burkart, F ^b,h   Dal Palu C ^c,h   Distler, A ^d   Hosie, J ^e   Logan, A G ^f   Menard J ^g   Pinto M De, S ^h,l   Pinto O De, S ^h,l   Rosenfeld, J B ^h   Taylor, S H ^i,l   Vesanen, K ^j   Watters, J T ^j   Artzenius, A C ^a   Behar, S ^h   Bird, S ⁱ   Bonjer, F H ^a   Bohler F R ^h   Neufeld, H N ^h   Rautaharju, P M ^k   Silke, B ⁱ   Ambroso, G ^l   Benson, K G ^l   Bethlen, L ^l   Bieri, R ^l   Dusseldorp S ^l   Greenberg, J ^l   Van Hamersveld, J D ^l   Lazzaretto, R ^l   Major, R ^l   Mitterhofer, T ^l   Parr, G D ^l   Solomon, P J ^l   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF PADOVA   (Italy)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e Glasgow   (United Kingdom)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ LEEDS GENERAL INFIRMARY   (United Kingdom)

^j Dalhousie University ^*

^k DALHOUSIE UNIVERSITY   (Canada)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Antihypertensive therapy; Blood pressure control; Cardiovascular risk factors; Myocardial infarct reduction; Oxprenolol; Smoking

Indexed keywords

AMILORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; GUANETHIDINE; HYDRALAZINE; METHYLDOPA; NIFEDIPINE; OXPRENOLOL; PLACEBO; PRAZOSIN; RESCINNAMINE; RESERPINE; SPIRONOLACTONE; TOBACCO SMOKE; TRIAMTERENE;

ADVERSE DRUG REACTION; ANXIETY; BRONCHOSPASM; CARDIOVASCULAR SYSTEM; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLD LIMB; CONTROLLED STUDY; DIGESTIVE SYSTEM; DOUBLE BLIND PROCEDURE; DREAMING; DYSPNEA; ESSENTIAL HYPERTENSION; FATALITY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEADACHE; HEART; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; IMPOTENCE; INTOXICATION; MAJOR CLINICAL STUDY; MALE GENITAL SYSTEM; MOUTH; NERVOUS SYSTEM; NEUROTOXICITY; NOCTURIA; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; SMOKING; SUDDEN DEATH; SWEATING; THERAPY; VERTIGO; XEROSTOMIA;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; DIURETICS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; OXPRENOLOL; PULSE; RANDOM ALLOCATION; RISK; SMOKING; SUPPORT, NON-U.S. GOV'T; SYMPATHOLYTICS; VASODILATOR AGENTS;

EID: 0022254994     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-198508000-00011     Document Type: Article

References (47)

1. Veterans Administration Cooperative Study Group on Antihypertensive Agents, Effects of treatment on morbidity in hypertension I. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg, JAMA 1967, 202:1028-1034.
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970, 213:1143-1152.
3. Goldman AL, Steele BW, Schnaper HW, Fitz AE, Frohlich ED, Perry HM Jr: Serum lipoprotein levels during chlorthalidone therapy. JAMA 1980, 244:1691-1695.
4. Duke M: Thiazide-induced hypokalemia: association with acute myocardial infarction and ventricular fibrillation. JAMA 1978, 239:43-46.
5. Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT: Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet 1982,11:1293-1295.
6. The Multiple Risk Factor Intervention Trial Research Group: Multiple risk factor intervention trial, risk factor changes and mortality results. JAMA 1982, 248:1465-1477.
7. Holme I, Helgeland A, Hjermann I, Leren P, Lundlarsen PG: Treatment of mild hypertension with diuretics; the importance of ECG abnormalities in the Oslo study and in MRFIT. JAMA 1984, 251:1298-1299.
8. Buhler FR, Bolli P: The cardioprotective potential of antihypertensive therapy based on betablockade. In Modulation of Sympathetic Tone in the Treatment of Cardiovascular Diseases edited by Gross F. Bern: Hans Huber, 1979, pp 259-266.
9. Dollery CT: Does it matter how blood pressure is reduced? Clin Sci 1981, 61:413s-420s.
10. May GS, Eberlein KA, Furberg CD, Passamani ER, DeMets DL: Secondary prevention after myocardial infarction: a review of long term trials. Prog Cardiovasc Dis 1982, 4:331-352.
11. Taylor SH, Silke B, Ebbutt A, Sutton GC, Prout BJ, Burley DM: A long-term prevention study with oxprenolol in coronary heart disease. N Engl J Med 1982, 307:1293-1301.
12. The European Infarction Study Group: A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality. Eur Heart J 1984, 5:189-202.
13. Berglund G, Wilhelmsen L, Sannersted R, Hansson L, Andersson O, Solvertsson R, Wedel H, Wikstrand J: Coronary heart disease after treatment of hypertension. Lancet 1978, 1:1-5.
14. The IPPPSH Collaborative Group: The International Prospective Primary Prevention Study in Hypertension (IPPPSH): objectives and methods. Eur J Clin Pharmacol 1984, 27:379-391.
15. Petrie JC, Jeffers TA, Robb OJ, Scott AK, Webster J: Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Br Med J 1980, 2:1573-1574.
16. Bolli P, Buhler FR, Raeder EA, Amann FW, Meier M, Rogg H, Burckhardt D: Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol. Circulation 1981, 64:1130-1134.
17. Rose GA, Blackburn H: Cardiovascular survey methods. Geneva: World Health Organization, 1968.
18. Rautaharju PB, Warren JW, Jain U, Wolf HK, Nielsen CL: Cardiac infarction injury score: an electrocardiographic coding scheme for ischemic heart disease. Circulation 1981, 64:249-256.
19. Bart AJM, Bonjer FH, Saaltink EML, Tuinstra CL: Detection of myocardial infarction by means of the cardiac infarction injury score. J Cardiovasc Pulmonary Technique 1985 (in press).
20. Kannel WB, Dawber TR: Hypertensive cardiovascular disease - the Framingham Study. In Hypertension - Mechanisms and Management edited by Onesti G, Kim KE, Moyer JH. New York: Grune and Stratton, 1973, pp 93-110.
21. Stamler J, Lindberg HA, Berkson DM, Shaffer A, Miller W, Poindexter A: Prevalence and incidence of coronary heart disease in strata of labor force of a Chicago industrial corporation. J Chronic Dis 1960, 2:405-420.
22. Paul O: Risks of mild hypertension: a ten year report. Br Heart J 1971, 33 (suppl): 115-121.
23. Chapman JM, Massex FJ Jr: The interrelationship of serum cholesterol, hypertension, body weight and risk of coronary heart disease. J Chronic Dis 1964, 17:933-949.
24. Keys A: Coronary heart disease in seven countries. Circulation 1970, 41 (suppl l):1-199.
25. Halperin M, Rogot E, Gurian J, Ederer F: Sample sizes for medical trials with special reference to long-term therapy. J Chronic Dis 1968, 21:13-24.
26. Schwarz D, Lellouch J: Explanations and pragmatic attitudes in therapeutic trials. J Chronic Dis 1967, 20:637-645.
27. Armitage P, Rose GA: The variability of measurements of casual blood pressure, 1. A laboratory study. Clin Sci 1966, 30:325-335.
28. Tukey JW: Exploratory Data Analysis. Reading MA: Addison- Wesley 1977.
29. Mantel N: Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963, 58:690-700.
30. Kaplan EL, Meier P: Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
31. Cox DR: Regression models and life-tables (with discussion). J R Stat Soc 1972, Series B, 34:182-202.
32. SAS Institute Inc: SUGI Supplemental Library User’s Guide. Cary NC: SAS Institute Inc., 1983.
33. McFate Smith W: Treatment of mild hypertension, results of a ten year trial, US Public Health Service Hospitals, Cooperative Study Group. Circ Res 1977, 40 (suppl 1):99-105.
34. The Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1980, 1:1261-1267.
35. The Management Committee of the Australian National Blood Pressure Study: Prognostic factors in the treatment of mild hypertension. Circulation 1984, 69:668-676.
36. Hypertension Detection and Follow-up Cooperative Group: Five year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979, 242:2562-2571.
37. Myocardial Infarction Community Registers: Public Health in Europe, 5. Copenhagen: World Health Organization, 1976.
38. Salonen JT, Puska P, Kottke TE: Smoking, blood pressure and serum cholesterol as risk factors of acute myocardial infarction and death among men in Eastern Finland. Eur Heart J 1981, 2:365-373.
39. Buhler FR, Burkart F, Lutold BE, Kung M, Marbet G, Pfisterer M: Antihypertensive beta-blocking action as related to renin and age: a pharmacological tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol 1975, 36:653-669.
40. Medical Research Council’s working party on mild to moderate hypertension: Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981, 11:539-543.
41. Kannel WB, Gordon T, Castelli WP: Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham Study. Ann Intern Med 1970, 72:813-822.
42. Pettinger WA: Clonidine, a new antihypertensive drug. N Engl J Med 1975, 293:1179-1180.
43. Hjermann I, Velve Byre K, Holme I, Leren P: Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet 1981, 11:1303-1310.
44. Puska P, lacono JM, Nissinen A, Korhonen HJ, Vartiainen E, Pietinen P, Dougherty R, Leino V, Mutanen M, Moisio S: Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet 1983, 1:1-9.
45. Rose G: Incubation period of coronary heart disease. Br Med J 1982, 284:1600-1601.
46. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J 1983, 287:867-870.
47. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984, 144:1045-1057